Obstetric and thrombotic outcomes among pregnant patients with myeloproliferative neoplasms: a propensity score matched real-world analysis
We performed a multicenter retrospective propensity score-matched cohort study using the TriNetX database to evaluate maternal, obstetric, and thrombotic outcomes among pregnant patients with MPN compared with matched non-MPN controls. Pregnancies in patients with MPN are associated with significantly increased maternal, obstetric, and venous thrombotic complications, highlighting the need for multidisciplinary management and individualized thromboprophylaxis strategies.
We performed a multicenter retrospective propensity score-matched cohort study using the TriNetX database to evaluate maternal, obstetric, and thrombotic outcomes among pregnant patients with MPN compared with matched non-MPN controls. Pregnancies in patients with MPN are associated with significantly increased maternal, obstetric, and venous thrombotic complications, highlighting the need for multidisciplinary management and individualized thromboprophylaxis strategies.
What the study was
- Study design
- Multicenter cohort study
- Population
- Patients
- Sample size
- 4563
- Category
- Other
- Maturity
- Exploratory
- Journal
- Annals of hematology
Why it surfaced
Matched Hematologic malignancies; Multicenter cohort study; human study; score 9/10 (n=2 r=3 dq=2 pop=2)
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.